The invention relates to a novel use of the antimuscarinic agent glycopyrrolate, for example the salt glycopyrronium bromide. In particular, the invention relates to glycopyrrolate for use as a heart rate lowering agent and more particularly, but not exclusively, for use in patients suffering from respiratory conditions such as chronic obstructive pulmonary disease.Una composición farmacéutica inhalable que comprende glicopirrolato o una de sus sales farmacéuticamente aceptable para uso en el tratamiento o profilaxis de la taquicardia.
